ArticleScientific reports2025
Acute lymphoblastic leukemia diagnosis using machine learning techniques based on selected features.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Automated leukemia detection from microscopic images using deep transfer learning with explainable AI-based analysis.Scientific reports · 2026Article
- Optimized deep learning ensemble using Fast Osprey algorithm for accurate lymphoblastic leukemia detection.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is considered one of the deadliest diseases worldwide. Early detection of cancer can significantly improve patient survival rates. In recent years, computer-aided diagnosis (CAD) systems have been increasingly employed in cancer diagnosis through various medical image modalities. These systems play a critical role in enhancing diagnostic accuracy, reducing physician workload, providing consistent second opinions, and contributing to the efficiency of the medical industry. Acute lymphoblastic leukemia (ALL) is a fast-progressing blood cancer that primarily affects children but can also occur in adults. Early and accurate diagnosis of ALL is crucial for effective treatment and improved outcomes, making it a vital area for CAD system development. In this research, a CAD system for ALL diagnosis has been developed. It contains four phases which are preprocessing, segmentation, feature extraction and selection phase, and classification of suspicious regions as normal or abnormal. The proposed system was applied to microscopic blood images to classify each case as ALL or normal. Three classifiers which are Naïve Bayes (NB), Support Vector Machine (SVM) and K-nearest Neighbor (K-NN) were utilized to classify the images based on selected features. Ant Colony Optimization (ACO) was combined with the classifiers as a feature selection method to identify the optimal subset of features among the extracted features from segmented cell parts that yield the highest classification accuracy. The NB classifier achieved the best performance, with accuracy, sensitivity, and specificity of 96.15%, 97.56, and 94.59%, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.